Kouki Miura

Phase II Trial of Trastuzumab and Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Salivary Duct Carcinoma

Hideaki Takahashi, Yuichiro Tada, Takashi Saotome et al. · Journal of Clinical Oncology · 2018 · 256 citations

Medicine, Oncology, Pharmacology +15

Neck Dissections Based on Sentinel Lymph Node Navigation Versus Elective Neck Dissections in Early Oral Cancers: A Randomized, Multicenter, and Noninferiority Trial

Yasuhisa Hasegawa, Kiyoaki Tsukahara, Seiichi Yoshimoto et al. · Journal of Clinical Oncology · 2021 · 140 citations

Medicine, Neck Surgery, Oncology +17

Clinicopathological significance of androgen receptor, HER2, Ki-67 and EGFR expressions in salivary duct carcinoma

Tatsuo Masubuchi, Yuichiro Tada, Shin-ichiro Maruya et al. · International Journal of Clinical Oncology · 2014 · 114 citations

Medicine, Cancer Biology, Oncology +17

Multicentre, retrospective study of the efficacy and safety of nivolumab for recurrent and metastatic salivary gland carcinoma

Kazutomo Niwa, Daisuke Kawakita, Toshitaka Nagao et al. · Scientific Reports · 2020 · 58 citations · Full text

Medicine, Oncology, Immunotherapy +13

Primary Tumor-Secreted Lymphangiogenic Factors Induce Pre-Metastatic Lymphvascular Niche Formation at Sentinel Lymph Nodes in Oral Squamous Cell Carcinoma

Naohiro Wakisaka, Yasuhisa Hasegawa, Seiichi Yoshimoto et al. · PLoS ONE · 2015 · 57 citations · Full text

Medicine, Oncology, Oral Pathology +17